<p><b>INTRODUCTION:</b> The Healthcare Program for Alzheimer's Disease Carriers established in 2002 that anticholinesterasic drugs should be provided on a free basis in Brazil.<br> <b>OBJECTIVES:</b> To evaluate the estimates for the program coverage based on data regarding the delivery of anticholinesterasics in several regions and states of Brazil.<br> <b>METHODOLOGY:</b> It was estimated the number of elderl...